ArcticZymes Technologies Logo

ArcticZymes Technologies

Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.

AZT | BR

Overview

Corporate Details

ISIN(s):
NO0010014632
LEI:
5967007LIEEXZXGR7K47
Country:
Norway
Address:
FORSKNINGSPARKEN, 9019 TROMSØ
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and sale of novel recombinant enzymes. With over 30 years of focused expertise, the company develops unique, high-performance enzymes, often derived from Arctic marine organisms, that are engineered to function in challenging conditions such as high-salt and low-temperature environments. Its products are critical components for customers in the molecular research, diagnostics (MDx), therapeutics, and biopharmaceutical manufacturing sectors, with key applications in gene therapy, vaccine production, and DNA purification. The company provides customized enzymatic solutions through close collaboration with its clients to advance molecular science.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 10:00
Investor Presentation
ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Co…
English 2.8 MB
2025-09-16 10:00
Investor Presentation
ArcticZymes Technologies presenterer på Pareto Securities 16 Healthcare Confere…
English 2.8 MB
2025-09-16 10:00
Report Publication Announcement
ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Co…
English 776 bytes
2025-09-16 10:00
Report Publication Announcement
ArcticZymes Technologies presenterer på Pareto Securities 16 Healthcare Confere…
Norwegian 693 bytes
2025-08-14 18:00
Director's Dealing
ArcticZymes Technologies ASA - Mandatory notification of trades by close associ…
English 205.9 KB
2025-08-14 18:00
Director's Dealing
ArcticZymes Technologies ASA - Mandatory notification of trades by close associ…
English 945 bytes
2025-08-14 07:00
Quarterly Report
ArcticZymes Technologies Reports Q2 and H1 2025 Results: Biomanufacturing Growt…
English 1.8 MB
2025-08-14 07:00
Investor Presentation
ArcticZymes Technologies Reports Q2 and H1 2025 Results: Biomanufacturing Growt…
English 2.5 MB
2025-08-14 07:00
Earnings Release
ArcticZymes Technologies Reports Q2 and H1 2025 Results: Biomanufacturing Growt…
English 308.2 KB
2025-08-14 07:00
Earnings Release
ArcticZymes Technologies Reports Q2 and H1 2025 Results: Biomanufacturing Growt…
English 6.7 KB
2025-08-07 08:31
Report Publication Announcement
ArcticZymes Technologies ASA: Invitation to presentation of Q2 and 6M 2025 resu…
English 1.1 KB
2025-06-16 07:00
Regulatory News Service
ArcticZymes Technologies Launches GMP-Grade Nuclease for Next-Generation Viral …
English 115.9 KB
2025-06-16 07:00
Regulatory News Service
ArcticZymes Technologies Launches GMP-Grade Nuclease for Next-Generation Viral …
English 3.1 KB
2025-06-04 11:10
Investor Presentation
ArcticZymes Technologies to present at Handelsbanken Small & Mid Cap Seminar 20…
English 3.0 MB
2025-06-04 11:10
Report Publication Announcement
ArcticZymes Technologies to present at Handelsbanken Small & Mid Cap Seminar 20…
English 754 bytes

Automate Your Workflow. Get a real-time feed of all ArcticZymes Technologies filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ArcticZymes Technologies via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
ADBIOTECH Co.,Ltd. Logo
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
South Korea 179530
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Develops user-friendly, saliva-based tests for health monitoring & therapeutic drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics, managing the full value chain from R&D to sales.
Japan 2927
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK
Alkaloid AD Logo
Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.
North Macedonia ALK
ALLERGY THERAPEUTICS PLC Logo
Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.
United Kingdom AGY
Alligator Bioscience Logo
Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.
Sweden ATORX

Talk to a Data Expert

Have a question? We'll get back to you promptly.